Core Viewpoint - Bitdeer Technologies Group has announced a registered direct offering of 10,661,140 Class A ordinary shares at a price of US$13.94 per share, aiming to raise approximately US$148.4 million in net proceeds, which will be used for various corporate purposes including debt repayment and business expansion [1][2][3]. Group 1: Offering Details - The registered direct offering is priced at US$13.94 per Class A ordinary share and is expected to close on November 19, 2025, subject to customary closing conditions [1]. - The net proceeds from the offering are estimated to be around US$148.4 million after deducting offering expenses [2]. - The offering is part of a broader strategy that includes a separate private offering of 4.00% Convertible Senior Notes due 2031, which is expected to generate approximately US$388.0 million in net proceeds [2]. Group 2: Use of Proceeds - Bitdeer plans to allocate approximately US$35.4 million of the proceeds to cover the costs of capped call transactions [3]. - An estimated US$267.9 million will be used to repurchase US$200.0 million of its 5.25% convertible senior notes due 2029 [3]. - Remaining proceeds will be directed towards datacenter expansion, ASIC-based mining rig development, and the growth of its HPC and AI cloud business, along with general corporate purposes [3]. Group 3: Transaction Contingencies - The completion of the registered direct offering is contingent upon the successful completion of the notes offering and the note repurchase transactions [4]. - The notes offering is not dependent on the completion of the registered direct offering or the note repurchase transactions [4]. Group 4: Company Overview - Bitdeer Technologies Group is a leading technology company specializing in Bitcoin mining and AI cloud solutions, providing comprehensive services including equipment procurement, datacenter design, and daily operations [7][8]. - The company is headquartered in Singapore and has established datacenters in the United States, Norway, and Bhutan [8].

Core Viewpoint - Bitdeer Technologies Group plans to offer $400 million in Convertible Senior Notes due 2031, with an option for an additional $60 million, to qualified institutional buyers, subject to market conditions [1][2] Group 1: Notes Offering - The notes will be senior unsecured obligations of Bitdeer, accruing interest payable semiannually, with conversion options including cash, Class A ordinary shares, or a combination of both [2] - The interest rate and conversion terms will be determined at the time of pricing [2] Group 2: Use of Proceeds - Proceeds from the notes offering will be used for capped call transactions, datacenter expansion, ASIC mining rig development, and general corporate purposes [3] - If additional notes are purchased, proceeds will similarly support capped call transactions and business expansions [3] Group 3: Capped Call Transactions - Bitdeer plans to enter capped call transactions to mitigate potential dilution from the conversion of the notes [4] - These transactions will cover the number of Class A ordinary shares underlying the notes [4] Group 4: Concurrent Offerings - Bitdeer intends to conduct a registered direct offering of Class A ordinary shares to fund the repurchase of its 5.25% convertible senior notes due 2029 [8][9] - The completion of the registered direct offering is contingent on the successful execution of the notes offering and note repurchase transactions [9] Group 5: Market Activity - The option counterparties may engage in derivative transactions that could influence the market price of Class A ordinary shares and the notes [5][6] - Hedged holders of the November 2029 notes may unwind their hedge positions, potentially impacting the market price of the shares [10] Group 6: Company Overview - Bitdeer is a leading technology company specializing in Bitcoin mining and AI cloud services, with operations in the United States, Norway, and Bhutan [13] - The company provides comprehensive solutions for Bitcoin mining, including equipment procurement and datacenter management [13]

Core Viewpoint - Bitdeer Technologies Group plans to offer Class A ordinary shares to holders of its 5.25% convertible senior notes due 2029 in a registered direct offering, subject to market conditions [1][2]. Group 1: Offering Details - The number of Class A ordinary shares and their price will be determined at the pricing of the registered direct offering [1]. - The registered direct offering is contingent on the completion of a separate notes offering and note repurchase transactions [2]. - Barclays Capital Inc. is acting as the placement agent, while ICR Capital LLC serves as the financial advisor for the offering [4]. Group 2: Use of Proceeds - Net proceeds from the registered direct offering will be used, along with proceeds from a separate notes offering, to repurchase a portion of the November 2029 notes [2]. Group 3: Company Overview - Bitdeer is a leading technology company specializing in Bitcoin mining and AI cloud solutions, providing comprehensive services including equipment procurement, logistics, datacenter design, and operations [5]. - The company is headquartered in Singapore and has datacenters in the United States, Norway, and Bhutan [5].

Core Viewpoint - Halozyme Therapeutics, Inc. has announced the pricing of $650 million in 0% convertible senior notes due 2031 and $650 million in 0.875% convertible senior notes due 2032, with an option for initial purchasers to buy an additional $100 million of each series [1][4]. Summary by Sections Convertible Notes Details - The 2031 Notes are senior, unsecured obligations with no regular interest and no principal accretion, while the 2032 Notes will accrue interest at an annual rate of 0.875% payable semi-annually [2]. - The initial conversion rate for both series is 11.4683 shares per $1,000 principal amount, equating to a conversion price of approximately $87.20 per share, representing a 27.5% premium over the closing price of $68.39 on November 6, 2025 [2]. Use of Proceeds - The company expects to receive net proceeds of approximately $1.274 billion, or $1.47 billion if the option for additional notes is fully exercised, after deducting discounts and expenses [4]. - Approximately $182.7 million of the proceeds will fund capped call transactions, while about $1.020 billion will be used to repurchase existing convertible notes due 2027 and 2028 [4][5]. Capped Call Transactions - Capped call transactions have been established to cover the shares underlying the convertible notes, with a cap price of $136.78 per share, representing a 100% premium over the last reported sale price [3][7]. - These transactions are expected to reduce potential dilution upon conversion of the notes and offset cash payments if the market price exceeds the cap price [7]. Market Impact - The note repurchases may influence the market price of the company's common stock and convertible notes, potentially affecting the conversion price and the number of shares received upon conversion [6][10]. - The company anticipates that hedging activities related to the capped call transactions could also impact the market price of its common stock [8][9]. Company Overview - Halozyme is a biopharmaceutical company focused on innovative drug delivery solutions, particularly through its ENHANZE® technology, which facilitates subcutaneous delivery of drugs [14][15]. - The company has partnered with major pharmaceutical firms and has a presence in over 100 global markets, impacting approximately one million patients [14].

Core Insights - MakeMyTrip reported a net loss of $5.7 million in Q2 FY26, a significant decline from a net profit of $17.9 million in the same quarter last year and a profit of $25.8 million in Q1 FY26 [2][4] - Operating revenue increased by 9% year-over-year to $229.3 million, but showed a 15% decline sequentially from $268.9 million [2][3] - The company's net finance cost surged to $35.9 million, up from $500,000 in the previous year, primarily due to a $24.3 million increase in interest expenses and $11.2 million in foreign exchange losses [1][3] Financial Performance - The operating revenue for Q2 FY26 was $229.3 million, compared to $211 million in the same quarter last year [2] - The net loss of $5.7 million in Q2 FY26 contrasts sharply with the net profit of $17.9 million reported in Q2 FY25 [2] - The sequential decline in revenue of 15% from $268.9 million in Q1 FY26 indicates potential challenges in maintaining growth [2] Financial Liabilities - The increase in interest expenses is attributed to a liability of $1.1 billion related to 0.00% convertible senior notes due 2030, issued on June 23, 2025 [4] - The company raised $3.1 billion through a combination of primary equity follow-on and convertible bonds in June, which included the issuance of these notes [4] Share and Debt Repurchase Program - MakeMyTrip has extended its share and debt repurchase program until March 31, 2030 [5] - The board has authorized the repurchase of convertible senior notes due 2028 and 2030, with a total repurchase limit of $200 million, including a sub-limit of $100 million per fiscal year [6]

Core Viewpoint - Cipher Mining Inc. has announced the pricing of a $1.1 billion offering of 0.00% convertible senior notes due 2031, increasing from a previously announced size of $800 million, with settlement scheduled for September 30, 2025 [1][5] Group 1: Offering Details - The notes will be senior, unsecured obligations of Cipher, maturing on October 1, 2031, and will not bear regular interest [2] - The initial conversion rate is set at 62.3733 shares of common stock per $1,000 principal amount of notes, equating to an initial conversion price of approximately $16.03 per share, representing a 37.5% premium over the last reported sale price of $11.66 on September 25, 2025 [2] - Cipher has granted initial purchasers a 13-day option to purchase up to an additional $200 million aggregate principal amount of notes [1] Group 2: Use of Proceeds - Cipher estimates net proceeds from the offering to be approximately $1.08 billion, or $1.27 billion if the option for additional notes is fully exercised, with plans to use $70 million for capped call transactions and the remainder for data center construction, HPC strategy acceleration, and general corporate purposes [5] Group 3: Capped Call Transactions - Cipher has entered into capped call transactions to cover the number of shares underlying the notes, with an initial cap price of $23.32 per share, a 100% premium over the last reported sale price [6] - These capped call transactions are expected to reduce potential dilution upon conversion of the notes and offset any cash payments exceeding the principal amount of converted notes [7] Group 4: Redemption and Repurchase - The notes are redeemable at Cipher's option starting October 5, 2028, if the last reported sale price exceeds 130% of the conversion price for a specified period [3] - In the event of a "fundamental change," noteholders may require Cipher to repurchase their notes for cash at the principal amount plus accrued interest [4]

Core Viewpoint - Nebius Group N.V. has announced the pricing of its offering of $2.75 billion in convertible senior notes, indicating a significant capital raise to support its AI infrastructure initiatives [1] Group 1: Offering Details - The offering consists of two series of convertible notes: $1,375 million of 1.00% convertible notes due in 2030 and $1,375 million of 2.75% convertible notes due in 2032 [1]

Core Viewpoint - Evolent Health, Inc. plans to offer $140 million in convertible senior notes due 2031, with an option for initial purchasers to buy an additional $20 million, aimed at improving financial flexibility and supporting share repurchases [1][2]. Group 1: Offering Details - The offering consists of $140 million aggregate principal amount of convertible senior notes due 2031, subject to market conditions [1]. - Evolent expects to use up to $100 million of the net proceeds to repurchase a portion of its existing 1.50% convertible senior notes due 2025 and approximately $40 million for repurchasing shares of its Class A common stock [2]. - The notes will be convertible into cash, shares of Evolent's Class A common stock, or a combination thereof, with interest payable semiannually starting February 15, 2026 [4]. Group 2: Repurchase Strategy - Evolent plans to repurchase shares of its Class A common stock sold short by initial investors at a price equal to the last reported sale price on the pricing date, which may influence the market price of the stock [3]. - The company anticipates that holders of the 2025 Notes who agree to have their notes repurchased may unwind their hedges by buying Evolent's Class A common stock, potentially affecting the stock price [6]. Group 3: Conversion Rights - The conversion rights of the notes may be terminated by Evolent on or after August 20, 2026, under specific conditions related to the stock price performance [5]. - The conversion price and other terms of the notes will be determined at the time of the offering's pricing [4]. Group 4: Regulatory Information - The notes and any Class A common stock issued upon conversion will not be registered under the Securities Act, and may only be offered to qualified institutional buyers [7]. - The press release does not constitute an offer to sell or a solicitation to buy the securities described [8]. Group 5: Company Overview - Evolent Health specializes in improving health outcomes for individuals with complex conditions, serving a national base of leading payers and providers [9].

Core Viewpoint - Centrus Energy is raising $650 million through convertible senior notes despite having sufficient cash flow and a healthy balance sheet, raising questions about the rationale behind this decision [1][5]. Group 1: Financial Details - Centrus Energy plans to issue $650 million worth of convertible senior notes due in 2032 to fund the development of high-assay, low-enriched uranium (HALEU) for advanced reactors [2]. - If there is enough interest from banks, the offering could be increased by $100 million, totaling $750 million [3]. - The interest rate for the notes has not been disclosed, but such notes typically pay below market rates, which could benefit the company [4]. Group 2: Company Performance - Centrus Energy has generated significant free cash flow of $107 million over the last 12 months, indicating no immediate cash need [5]. - The company currently holds more cash than debt, suggesting a strong financial position [5]. Group 3: Market Reaction - Following the announcement, Centrus Energy's shares fell by 9.9%, indicating investor skepticism regarding the need for the cash raise [1]. - Despite the market reaction, there is speculation that the company may have strategic plans for its HALEU business, which could justify the capital raise [6].

Core Viewpoint - Array Technologies, Inc. plans to offer $250 million in convertible senior notes due 2031, with an option for initial purchasers to buy an additional $37.5 million, subject to market conditions [1][4]. Group 1: Offering Details - The notes will be senior, unsecured obligations of Array Technologies, accruing interest payable semiannually [2]. - The interest rate and initial conversion rate will be determined at the time of pricing the offering [3]. - The net proceeds from the offering will be used to repay $150 million of outstanding indebtedness, fund capped call transactions, and for general corporate purposes [4]. Group 2: Capped Call Transactions - Array intends to enter into capped call transactions to cover the shares underlying the notes, which will help reduce potential dilution upon conversion [5]. - The option counterparties may purchase shares of Array's common stock or enter into derivative transactions, potentially affecting the market price of the stock [6]. Group 3: Existing Convertible Notes - Array may negotiate to repurchase a portion of its existing 1.00% Convertible Senior Notes due 2028 using proceeds from the offering [7]. - The terms of any repurchase of existing convertible notes will be negotiated individually with each holder [7]. Group 4: Company Overview - Array Technologies is a leading provider of solar tracking technology, focusing on maximizing energy production for utility-scale and distributed generation customers [10].